The Return on Equity (ROE) of Fusen Pharmaceutical Co Ltd (1652.HK) is -51.07%.
Return on Equity (ROE) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -51.07% |
| 2023-12-31 | -6.44% |
| 2022-12-31 | -5.63% |
| 2021-12-31 | 2.53% |
| 2020-12-31 | 10.63% |
| 2019-12-31 | 7.93% |
| 2018-12-31 | 16.59% |
| 2017-12-31 | 53.62% |
| 2016-12-31 | 78.53% |
| 2015-12-31 | 23.67% |